Investors

Invest in Cymra Life Sciences

The legalisation of medical cannabis marks an exciting time in healthcare. It’s a brand new industry with huge opportunities. Cymra Life Sciences combines pharmaceutical industry expertise and plant based science to deliver the high quality whole plant medical cannabis to the Australian market.

In 2018, Cymra secured licences from the Office of Drug Control for both the cultivation and manufacturing of cannabis oil, one of just a few Australian companies to own the full supply chain including cultivation, production, manufacturing and distribution.

The philosophy of Cymra places innovation and Intellectual Property at the core of our business around genetics and pharmaceutical drug development

If you’re an investor and interested in understanding more about Cymra Life Sciences, please get in touch today: info@cymra.com.au

Want to keep up to date with the latest Medical Cannabis Information in Australia and from around the world?

We will send you informative information from time to time so you can learn about cannabis and if it can help you.

Shareholders

If you are interested in accessing our AGM content and agenda please click here  https://drive.google.com/file/d/1cNoaS71wFnINSJYKFv3frxlE6z9kxy8l/view?usp=sharing

If you are having trouble with access please email Simon or Joel 

Cymra Blog

From time to time our team publishes interesting content that we feel is valuable to the wider community.

Cymra News

We try to keep stakeholders updated on our progress and the latest things coming out of our company.